|
Asian flu reaches Minnesota, more than 80 dairy herds now reported infected across 11 states |
mike kraft |
Group Post |
06/07/24 |
|
Asian-Pacific countries, lagging in jabs, still rely on supression tactics |
mike kraft |
Group Post |
06/22/21 |
|
Aspirin to be investigated as a possible treatment for COVID-19 in the RECOVERY trial |
mike kraft |
Group Post |
11/06/20 |
|
Assessment of pandemic's effect on mental health in Europe |
mike kraft |
Group Post |
06/20/23 |
|
Assessment of the impact of war on the enviornment and health and recover in Ukraine l |
mike kraft |
Group Post |
09/19/22 |
|
Asthma patients report worse asthma control after COVID-19 |
mike kraft |
Group Post |
02/16/23 |
|
Astra antibody cocktail did not prevent COVID-19 symptoms in large trial |
mike kraft |
Group Post |
06/15/21 |
|
AstraZeneca admits its Covid vaccine can cause rare side effect -- British court documents |
mike kraft |
Group Post |
04/29/24 |
|
AstraZeneca antibody cocktail study shows success treating COVID-19 |
mike kraft |
Group Post |
10/11/21 |
|
AstraZeneca asks FDA for emergency authorization for new COVID treatment |
Naomisfreeman |
Group Post |
10/06/21 |
|
AstraZeneca commits to releasing more complete vaccine data after concerns from NIH |
mike kraft |
Group Post |
03/23/21 |
|
AstraZeneca court case: EU says company did ‘not even try’ to meet Covid vaccine contract |
mike kraft |
Group Post |
05/26/21 |
|
AstraZeneca COVID drug neutralises Omicron sub-variants in lab study |
mike kraft |
Group Post |
03/21/22 |
|
AstraZeneca COVID therapy getts backing from EU regulator |
mike kraft |
Group Post |
09/16/22 |
|
AstraZeneca COVID-19 vaccine shows 74% efficacy in large U.S. trial |
mike kraft |
Group Post |
09/29/21 |
|
AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K. |
mike kraft |
Group Post |
09/08/20 |
|
AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - Reuters sources |
mike kraft |
Group Post |
09/15/20 |
|
AstraZeneca developments: Oxford suspends trial with children, European official says casual link with rare blot cots |
mike kraft |
Group Post |
04/06/21 |
|
AstraZeneca resumes trials of COVID vaccine halted by patient illness |
mike kraft |
Group Post |
09/12/20 |
|
AstraZeneca safety controversy, shipping issues |
mike kraft |
Group Post |
03/12/21 |
|
AstraZeneca says COVID vaccine as effective as mRNA shots in review |
mike kraft |
Group Post |
07/13/22 |
|
AstraZeneca says COVID-19 'vaccine for the world' can be 90% effective |
mike kraft |
Group Post |
11/23/20 |
|
AstraZeneca says early trial data indicates third dose helps against Omicron |
mike kraft |
Group Post |
01/13/22 |
|
AstraZeneca says EU loses legal bid for more vaccine supplies by end-June |
mike kraft |
Group Post |
06/18/21 |
|
AstraZeneca says it is on track to meet Southeast Asia vaccine orders |
mike kraft |
Group Post |
06/28/21 |
|
AstraZeneca says its vaccine is effective against COVID-19 variants identified in India |
mike kraft |
Group Post |
06/22/21 |
|
AstraZeneca seeks U.S. FDA authorisation of drug to prevent COVID-19 |
mike kraft |
Group Post |
10/05/21 |
|
AstraZeneca shot is good if safety issues can be overcome, U.S. official Fauci says |
mike kraft |
Group Post |
04/13/21 |
|
AstraZeneca shots have good risk-benefit profile for over 60s, says EMA official |
mike kraft |
Group Post |
06/13/21 |
|
AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official |
mike kraft |
Group Post |
02/23/21 |
|
AstraZeneca vaccine “did not show protection” against mild cases of variant found in South Africa, |
mike kraft |
Group Post |
03/16/21 |
|
AstraZeneca vaccine: Status report on which countries are using and which ones are suspending |
mike kraft |
Group Post |
04/01/21 |
|
AstraZeneca Vaccines Made at Troubled Baltimore Plant Were Shipped to Canada and Mexico |
mike kraft |
Group Post |
04/24/21 |
|
AstraZeneca' says its antibody cocktail helps prevent COVID-19 for at least 6 months |
mike kraft |
Group Post |
11/18/21 |
|
AstraZeneca's coronavirus vaccine becomes third to begin Phase three trials in the United States |
mike kraft |
Group Post |
09/01/20 |
|
AstraZeneca's coronavirus vaccine plausibly linked to rare brain clots, European regulators say |
mike kraft |
Group Post |
04/07/21 |
|
AstraZeneca's COVID vaccine suffers a setback in nasal spray trial |
mike kraft |
Group Post |
10/11/22 |
|
AstraZeneca, maker of FluMist, seeks to allow at-home administration of vaccine |
mike kraft |
Group Post |
10/25/23 |
|
AstraZeneca, Pfizer vaccines both effective against Delta COVID-19 variants-study |
mike kraft |
Group Post |
06/23/21 |
|
AstraZeneca, Under Fire for Vaccine Safety, Released Trial Blueprints |
mike kraft |
Group Post |
09/22/20 |
|
AstraZeneca: Researchers race to understand why handful of patients develop blot clots |
mike kraft |
Group Post |
04/07/21 |
|
AstraZeneca: ‘Winning’ vaccine formula is 100% effective against severe COVID-19 |
mike kraft |
Group Post |
12/27/20 |
|
AstraZenic withdraws its Covid vaccinie from market, EU says it is no longer authorized |
mike kraft |
Group Post |
05/08/24 |
|
At a glance: Europe's coronavirus curfews and lockdowns |
mike kraft |
Group Post |
01/14/21 |
|
At least 30 strikes of health care workers have hit U.S. facilities this year |
mike kraft |
Group Post |
10/20/21 |
|
At least 31 states set their one-day coronavirus case records in October |
mike kraft |
Group Post |
11/01/20 |
|
At least 85 percent of the world’s population has been affected by human-induced climate change-- new study |
mike kraft |
Group Post |
10/12/21 |
|
At least one long-term symptom seen in 37% of COVID-19 patients -study |
Naomisfreeman |
Group Post |
09/29/21 |
|
AT UN, World leaders pledge billions to fight AIDS, tuberculosis, malaria |
mike kraft |
Group Post |
09/22/22 |
|
AT WHO talks on pandemic pact, developing countries seek fairness |
mike kraft |
Group Post |
12/09/22 |
Recent Comments